Blood pressure changes following carotid endarterectomy were studied in 39 patients undergoing 42 carotid endarterectomies, in order to establish the incidence of hypertension and to study the use of hydrallazine for its treatment. Hypertension occurred in 28 cases (66%) and was treated with intravenous hydrallazine in a dose of 20 ± 8 mg; this resulted in a systolic blood pressure fall of 46 ± 22 mmHg, diastolic blood pressure fall of 24 ± 12 mmHg, mean blood pressure fall af 31 ± 15 mmHg, and a pulse rate increase af 7 ± 9 beats per minute. Hydrallazine is a safe, effective drug far the treatment af intraoperative hypertension.
INTRODUCTION
Intra-operative hypertension is a frequent problem in patients undergoing cardiovascular surgery.! It is a difficult problem because it can be associated with serious complications of the cardiovascular and central nervous systems, but the management may necessitate the use of very potent anti-hypertensive agents, the side effects of which may produce equally serious complications.
During carotid endarterectomy, the blood pressure may be very labile with both hypotension and hypertension; however, following carotid endarterectomy, hypertension is a more common problem. 2 This hypertension must be treated in order to prevent cerebral oedema,3 haemorrhage from the arteriotomy site and myocardial infarction. 4 This study of patients having carotid endarterectomy was aimed firstly at establishing the incidence of intra-operative post carotid endarterectomy hypertension. Hypertension was defined as a blood pressure greater than 160 mmHg systolic or 100 mmHg diastolic 5 or if it was associated with myocardial ischaemia caused by increased afterload and manifest on the ECG as ST depression or ventricular extrasystoles. 6 Secondly, the study was aimed at investigating the use of hydrallazine in the treatment of intra-operative hypertension. The study was not aimed at determining if post carotid endarterectomy hypertension should or should not be treated. Previous investigators 7 ,8 recommended that post carotid endarterectomy hypertension should be treated. However, the question could only be resolved if a randomised trial involving a comparison of treated and untreated patients was carried out and this we felt was not ethical.
MATERIALS AND METHODS
The study was carried out on 39 consecutive patients having 42 elective carotid endarterectomies and who were anaesthetised by the authors. There were 21 males and 18 females, aged 61 ± 8 years and weighing 69 ± 13 kg.
Nineteen patients had a pre-operative diagnosis of hypertension, were taking effective anti-hypertensive therapy and had normal blood pressures pre-operatively. Fourteen patients had clinically diagnosed coronary artery disease, though a number of others would have had coronary artery disease without clinical manifestations. The indications for carotid endarterectomy were predominantly transient ischaemic attacks.
Most of the patients were premedicated with pethidine 50 to 100 mg, and promethazine 25 mg given intramuscularly approximately one hour prior to induction of anaesthesia. Induction of anaesthesia was carried out with diazepam and thiopentone, intubation facilitated with pancuronium or aicuronium, and anaesthesia maintained with 66070 nitrous oxide and incremental doses of fentanyl or occasionally halothane. The patients were ventilated to maintain their arterial carbon dioxide tension at 35-40 mmHg. At the end of the surgery, the relaxant was reversed with neostigmine and atropine, and the patients were extubated.
Monitoring during the procedure consisted of continued assessment of clinical signs, supplemented with continuous intra-arterial blood pressure monitoring from the radial artery and the ECG using the CM5 configuration of leads for detection of myocardial ischaemia. 9 After the carotid endarterectomy was completed, but prior to emergence from anaesthesia, blood pressure in excess of 160/100 mmHg, or that associated with extrasystoles or ST depression on ECG, was treated with hydrallazine. The intra-arterial blood pressure and ECG were recorded on a two channel paper recorder running at 5 mm/second before giving the hydrallazine and at 5 minutes and 10 minutes after giving the drug (Figure 1 ). Undiluted hydrallazine was given intravenously in an initial dose of 10 mg or 20 mg (depending on the degree of hypertension) and then 10 mg at 5 minute intervals until a satisfactory blood pressure was obtained. If the administration of hydrallazine resulted in a tachycardia, or the patient had a tachycardia in excess of 90 beats/minute, then Anaesthesia and Intensive Care, Vol. VUl, No. 2. May, 1980 the patient was also given 2 to 4 mg of practolol intravenously to reduce the pulse rate to below 90 beats/minute. Light anaesthesia was excluded as a cause of the hypertension by ensuring that there was no patient movement or sweating, and that the blood pressure did not change in response to 100 mg of thiopentone intravenously.
Postoperatively, most of the patients were admitted to the Intensive Care Unit for continued care and monitoring, including intraarterial pressure monitoring and ECG monitoring. In this period we noted the incidence of postoperative hypertension, wound haematoma formation and neurological lesions.
RESULTS
Hypertension requiring treatment occurred in 28 of the carotid endarterectomies (66070). It was interesting to note that of the patients who had a pre-operative diagnosis of hypertension (19 patients), six (32070) did not develop intraoperative hypertension, and in the patients who were not diagnosed pre-operatively as hypertensive, fourteen (70070) developed intraoperative hypertension. The blood pressure and pulse rate ranges before hydrallazine in the patients who developed intra-operative hypertension are shown in Figure 2 . The majority of patients had systolic hypertension, eight patients had associated ST depression of 2 mm or greater, and one patient had extrasystoles caused by the hypertension. Figure 3 shows the effect of treatment with hydrallazine. The fall in systolic blood pressure was 46 ± 22 mmHg, diastolic blood pressure 24 ± 12 mmHg, and mean blood pressure 31 ± 15 mmHg. The pulse rate increased by an average of 7 ± 9 beats/minute. There were no cases in which hydrallazine caused hypotension (blood pressure <. 100 mmHg systolic). The mean dose of hydrallazine being required was 20 ± 8 mg. Ten patients required beta-blocker therapy, four because hydrallazine caused a significant rise in pulse rate, and six because the heart rate was already in excess of 90 beats/minute. Postoperative hypertension developed in two patients (15070) who did not have intraoperative hypertension, and five patients (18%) who were treated intra-operatively with hydrallazine. Postoperative transient hypotension (blood pressure < 100 mmHg systolic) occurred in three patients, two of whom did not have intra-operative hypertension, and one who received hydrallazine.
Permanent neurological sequelae occurred in four patients and transient sequelae in five patients, these were all in the group of patients who developed intra-operative hypertension.
Haematoma in the neck occurred on four occasions, three of these in the group of patients who had intra-operative hyptertension, though only one was caused by arterial bleeding.
One patient died from a probable postoperative myocardial infarct; this patient did have intraoperative hypertension and died 12 hours postoperatively.
DISCUSSION
Intra-operative hypertension should be treated following carotid endarterectomy for two main reasons; firstly to prevent the onset of cerebral oedema, and secondly to reduce the chance of developing postoperative myocardial infarction.
Patients having carotid endarterectomy are at greater risk of developing cerebral oedema because cerebral autoregulation may be impaired by minor degrees of cerebral hypoxia lo during carotid artery crossclamping, ) ) and if halothane is used during anaesthesia. 3 If cerebral autoregulation is impaired then acute hypertension, particularly if a carotid stenosis has been removed, can cause cerebral oedema l2 resulting in postoperative neurological sequelae.
In our study neurological sequelae occurred only in the group that had post carotid endarterectomy hypertension. This agrees with the view of both Lehv 8 and Bove\ that post carotid endarterectomy hypertension is associated with deterioration of neurological function. Lehv 8 found an incidence of post carotid endarterectomy hypertension of 56%, nearly half (47%) of these patients showed some deterioration of neurological function, 71 % of which persisted for longer than one week. Bove (1979) found the incidence of post carotid endarterectomy hypertension to be 19% and 10% of these patients incurred fixed neurological deficit. In both papers there were no neurological sequelae in patients who were normotensive post-operatively. We therefore consider that by treating post carotid endarterectomy hypertension early and preventing cerebral oedema, we may reduce the incidence of post carotid endarterectomy neurological sequelae.
Coronary artery disease is associated with arteriosclerotic carotid disease, and, in fact, myocardial infarction is the second most common cause of morbidity and death post carotid endarterectomy. 13 Acute systolic hypertension increased myocardial oxygen demand,14 and can be associated with myocardial ischaemia and infarction 15 in patients who have pre-operative hypertension. This also applies to patients who have coronary artery disease. 4 , 16 We therefore consider that treatment of post carotid endarterectomy hypertension should reduce the incidence of postoperative myocardial infarction.
There is a wide choice of therapy for treatment of intra-operative hypertension, but most have significant disadvantages. Halothane could be used but this depresses cardiac output, may lead to prolonged recovery and simply delays the onset of hypertension until the postoperative period. 6 Sodium nitroprusside and trimethapan are potent effective antihypertensive agents, but must be given by intravenous infusion using an accurate mechanical method of controlling infusion rate and their effect should be monitored using intra-arterial blood pressure monitoring. Diazoxide is again effective but its characteristic steep, sudden and unpredictable fall in blood pressure 17 we feel disqualifies it as a useful agent during anaesthesia.
Hydrallazine can however be given by intravenous bolus injection, has a gentle onset over about five minutes, reduces blood pressure to normal levels without hypotension and has a duration of action of about three hours which is similar to the average duration of post carotid endarterectomy hypertension of 5.6 hours. 7 It acts directly on vascular smooth muscle, decreasing peripheral resistance and increasing cardiac output. 18 Its main disadvantage is that it can cause tachycardia in a small number of patients (15070) and if this is not treated then the anti-hypertensive effect may be negated and myocardial oxygen demand will rise. This problem is however readily treated by small doses of practolol.
CONCLlISION
Post carotid endarterectomy hypertension, as defined in this study, is a very common event occurring in 66070 of the operations studied. The incidence is similar in patients who have diagnosed hypertension pre-operatively to those who are normotensive pre-operatively.
Hydrallazine given intravenously in an initial dose of 10 mg or 20 mg (depending on the degree of hypertension) and then 10 mg at 5 minute intervals until a satisfactory blood pressure is obtained is a safe, effective and simply administered drug for the treatment of intra-operative hypertension. Its main disadvantage of increase in pulse rate can readily be prevented or treated with 2 to 4 mg of practolol.
